COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,646 Articles (22,913 medRxiv, 8,733 bioRxiv)

Most recent first Previous |  Page 1169: Articles 11681-11690  | Next

AI/ML Models to Aid in the Diagnosis of COVID-19 Illness from Forced Cough Vocalizations: Good Machine Learning Practice and Good Clinical Practices from Concept to Consumer for AI/ML Software Devices
Kelley, K., Kelley, M., Kelley, S. C., Sakara, A. A., Ramirez, M. A.
10.1101/2021.11.13.21266289 — Posted: 2021-11-15
Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro
Hameedi, M. A., Teixeira Prates, E., Garvin, M. R., Mathews, I., Amos, B. K., Demerdash, O., Bechthold, M., Iyer, M., Rahighi, S., Kneller, D. W., Kovalevsky, A., Irle, S., Vuong, V.-Q., Mitchell, J. C., Labbe, A., Galanie, S., Wakatsuki, S., Jacobson, D.
10.1101/2021.11.11.468228 — Posted: 2021-11-15
Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2
Chen, I., Longbotham, J. E., McMahon, S., Suryawanshi, R., Carlson-Stevermer, J., Gupta, M., Zhang, M. Y., Soveg, F. W., Hayashi, J. M., Taha, T. Y., Lam, V. L., Li, Y., Yu, Z., Titus, E. W., Diallo, A., Oki, J., Holden, K., QCRG Structural Biology Consortium, , Krogan, N. J., Fijimori, D. G., Ott, M.
10.1101/2021.11.14.468537 — Posted: 2021-11-15
Full protection against all four SARS-CoV-2 variants of concern (VOC) in hamsters requires revision of spike antigen used for vaccination.
Sharma, S., Vercruysse, T., Sanchez-Felipe, L., Kerstens, W., Abdelnabi, R., Foo, C. S., Lemmens, V., Van Looveren, D., Maes, P., Baele, G., Weynand, B., Lemey, P., Neyts, J., Thibaut, H. J., Dallmeier, K.
10.1101/2021.11.12.468374 — Posted: 2021-11-15
Mutagenic distinction between the receptor-binding and fusion subunits of the SARS-CoV-2 spike glycoprotein
Penner, R. C.
10.1101/2021.11.15.468283 — Posted: 2021-11-15
#COVIDisAirborne: AI-Enabled Multiscale Computational Microscopy of Delta SARS-CoV-2 in a Respiratory Aerosol
Dommer, A., Casalino, L., Kearns, F., Rosenfeld, M., Wauer, N., Ahn, S.-H., Russo, J., Oliveira, S., Morris, C., Bogetti, A., Trifan, A., Brace, A., Sztain, T., Clyde, A., Ma, H., Chennubhotla, C., Lee, H., Turilli, M., Khalid, S., Tamayo-Mendoza, T., Welborn, M., Christiansen, A., Smith, D. G. A., Qiao, Z., Sirumalla, S. K., O'Connor, M., Manby, F., Anandkumar, A., Hardy, D., Phillips, J., Stern, A., Romero, J., Clark, D., Dorrell, M., Maiden, T., Huang, L., McCalpin, J., Woods, C., Gray, A., Williams, M., Barker, B., Rajapaksha, H., Pitts, R., Gibbs, T., Stone, J., Zuckerman, D., Muholland, A., Miller, T., Jha, S., Ramanathan, A., Chong, L., Amaro, R. E.
10.1101/2021.11.12.468428 — Posted: 2021-11-15
Estimation of R0 for the spread of SARS-CoV-2 in Germany from Excess Mortality
Prada Salcedo, J. P., Maag, L. E., Siegmund, L., Bencurova, E., Chunguang, L., Koutsilieri, E., Dandekar, T., Scheller, C.
10.1101/2021.11.14.21266295 — Posted: 2021-11-15
Early and rapid identification of COVID-19 patients with neutralizing type I-interferon auto-antibodies by an easily implementable algorithm
Akbil, B., Meyer, T., Stubbemann, P., Thibeault, C., Staudacher, O., Niemeyer, D., Jansen, J., Muehlemann, B., Doehn, J.-M., Tabeling, C., Nusshag, C., Hirzel, C., Soekler Sanchez, D., Nieters, A., Lother, A., Duerschmied, D., Schallner, N., Lieberum, J. N., August, D., Rieg, S., Falcone, V., Hengel, H., Koelsch, U., Unterwalder, N., Huebner, R.-H., Jones, T. C., Suttorp, N., Drosten, C., Warnatz, K., Spinetti, T., Schefold, J. C., Doerner, T., Sander, L., Corman, V. M., Merle, U., Kurth, F., von Bernuth, H., Meisel, C., Goffinet, C.
10.1101/2021.11.12.21266249 — Posted: 2021-11-15
Seroprevalence in Tamil Nadu through India's two COVID waves: Evidence on antibody decline following infection and vaccination
Selvavinayagam, T. S., Somasundaram, A., Selvam, J. M., Ramachandran, S., P., S., V., V., C., A. B. K., Subramanian, S., Raju, S., V., P., N., Y., Subramanian, G., A., R., D.N., D., Imad, S., Tandel, V., Parasa, R., Sachdeva, S., Malani, A.
10.1101/2021.11.14.21265758 — Posted: 2021-11-15
Comparative analysis of antibody production by mRNA 1273, AZD 1222 and BBIBP-CorV on elderly people suffering from different co-morbidity in Bangladesh
hoque, a., Rahman, M., Parvez, S., Imam, H., Nahar, N., Chowdhury, F. U. H.
10.1101/2021.11.15.21266338 — Posted: 2021-11-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).